Navigation Links
Diversionary Therapy Announces First Sale of ditto™ dental
Date:5/22/2012

NEW YORK, May 22, 2012 /PRNewswire/ -- Diversionary Therapy Technologies (DTT) is pleased to announce the first sale of its innovative new product, ditto™ dental, to Manhattan Pediatric Dental Group PC.   "We're excited to add ditto dental to our state-of-the-art pediatric dental care.  We trialed it in our office and had spectacular results," states Dr. Mark Hochberg, principal, of Manhattan Pediatric Dental Group.

ditto™ dental is a clinical tool developed from medical research which has been shown to reduce anxiety and stress for children aged 3-14 years. The procedural stories, covering all dental procedures, are chosen from the dentist menu to help prepare the children and their families for their treatment. By showing the videos before the procedure, treatment times have been shortened, anxiety reduced and better overall patient outcomes have resulted.  The portable device uses augmented reality, a multi-modal sensory-based distraction medium to engage children.  The user interface has other fun tangible interaction thanks to the touch screen and the motion sensors and can be used in a variety of positions.

Dr. Hochberg also added, "Taking your child to the dentist can be a very stressful experience for some children. It is important for us to be able to manage the child and reduce their apprehension during pediatric dental procedures.  We have purchased several devices because we found that showing the ditto™ dental pre-procedural videos helped relieve anxiety and lead to a better patient outcome."

The console also includes interactive games and immersive stories to engage the patient while waiting for procedures.  Pediatric dentists, orthodontists, child life specialists and animation experts have developed the ditto™ dental over the past couple of years and new content will continue to be added.

DTT will formally debut the ditto™ dental at the American Academy of Pediatric Dentistry 65th Annual Session in San Diego May 24-27. "We're looking forward to showing our device to over 2500 of the leading pediatric dentists in the United States.  We've had great feedback so far and it should be an exciting experience," say Steven Jenkins, CEO of DTT's North American operations.   

About Diversionary Therapy Technologies

Diversionary Therapy Technologies is a global company headquartered in Australia that masterminded the development of ditto™ portable device.  DTT worked with The Royal Children's Hospital, Brisbane, to create the handheld, waterproof device that is used prior to and during painful medical procedures to reduce children's anxiety.  Learn more at www.dtt-usa.com.

About Manhattan Pediatric Dental Group PC

Manhattan Pediatric Dental Group has provided the children of New York, and surrounding areas with the highest standard of state-of-the-art pediatric dental care for over 25 years. You can visit them at www.smiles4kids.com.


'/>"/>
SOURCE Diversionary Therapy Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
2. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
3. FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting
4. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
5. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
6. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
7. Progenitor Cell Therapy Secures Industry Accreditation
8. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
9. Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
10. First Coast Oncology to Offer Next Generation Proton Therapy
11. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... is now being assessed in clinical trials in the United States. (clinicaltrials.gov : ... your nurse or physician or find your nearest participating clinic here https://factor-therapeutics.com/clinical-trials/ ...
(Date:9/21/2017)... , ... September 21, 2017 , ... Dr. Greg Leyer, ... Vegas, NV on September 27th. His presentation is at 12:10pm in the Probiotics Resource ... to present at SupplySide West and discuss how probiotics have shown impressive data in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Colpitts Clinical has launched the ... includes new features that facilitate streamlined and compliant communication, file sharing and document ... forefront of medical advancements, they rely on efficiencies to help them address the ...
(Date:9/21/2017)... New Jersey (PRWEB) , ... September 21, 2017 ... ... highly-regulated pharmaceutical and clinical research sector professionals, has announced the addition of 5 ... Part 11 training - Compliance with Regulation 21 CFR Part 11 on ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):